A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Chronic Refractory Cough (CRC) With Non-atopic Asthma Clinical Trial

Official title: A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Status Recruiting

Clinical Trial Summary

This Phase IIa, multicenter, randomized, double-blind, placebo-controlled, crossover study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamic (PD) effects of GDC-6599 compared with placebo in patients with a history of chronic cough.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Asthma
• Bronchitis
• Bronchitis, Chronic
• Chronic Cough
• Cough
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

• NCT number: NCT05660850
• Study type: Interventional
• Source: Genentech, Inc.
• Contact: Reference Study ID Number: GA43590, https://forpatients.roche.co
• Phone: 888-662-6728 (U.S.)
• Email: global-roche-genentech-trials@gene.com
• Status: Recruiting
• Phase: Phase 2
• Start date: March 22, 2023
• Completion date: September 15, 2024